cidofovir anhydrous has been researched along with prednisolone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Araullo-Cruz, T; Gordon, YJ; Romanowski, EG | 1 |
| Goldstein, D; Kelly, J; Lloyd, A; Rawlinson, W; Senanayake, S; Waliuzzaman, Z | 1 |
| Aebi, C; Leibundgut, K; Ridolfi Lüthy, A; Steiner, I; Wagner, B | 1 |
| Adam, R; Breddemann, A; Harjes, M; Läer, S; Ludwig, A; Niehues, T; Schmidt, KG; Schneider, DT | 1 |
| Hackenbroch, M; Hallek, M; Rath, T; Rubbert, A; Saech, J | 1 |
| Connor, TB; Desai, S; Kopplin, LJ | 1 |
1 review(s) available for cidofovir anhydrous and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for cidofovir anhydrous and prednisolone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Conjunctiva; Conjunctivitis, Viral; Cytosine; Drug Therapy, Combination; Female; Glucocorticoids; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Prednisolone; Rabbits; Virus Replication | 1997 |
Multicentric Castleman's disease treated with antivirals and immunosuppressants.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antiviral Agents; Castleman Disease; Chlorambucil; Cidofovir; Cytosine; Drug Therapy, Combination; Foscarnet; Herpesvirus 8, Human; Humans; Immunosuppressive Agents; Male; Organophosphonates; Organophosphorus Compounds; Prednisolone; Sarcoma, Kaposi; Treatment Outcome | 2003 |
Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia.
Topics: Adenovirus Infections, Human; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Child, Preschool; Cidofovir; Computer Systems; Cytosine; DNA, Viral; Fatal Outcome; Hepatitis, Viral, Human; Humans; Immunocompromised Host; Male; Mercaptopurine; Methotrexate; Multiple Organ Failure; Organophosphonates; Polymerase Chain Reaction; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Vincristine; Viremia | 2008 |
Case report: severe gastrointestinal inflammation and persistent HHV-6B infection in a paediatric cancer patient.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antiviral Agents; Astrocytoma; Cidofovir; Cytosine; Diarrhea; Drug Therapy, Combination; Gastrointestinal Diseases; Herpesvirus 6, Human; Humans; Immunosuppression Therapy; Infant; Inflammation; Male; Organophosphonates; Prednisolone; Roseolovirus Infections; Treatment Outcome | 2007 |
Longterm remission of more than 5 years in a patient with progressive multifocal leucoencephalopathy and sarcoidosis.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Brain; Cidofovir; Cytosine; Female; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Methotrexate; Mianserin; Middle Aged; Mirtazapine; Organophosphonates; Prednisolone; Receptor, Serotonin, 5-HT2A; Sarcoidosis; Serotonin Antagonists | 2012 |
Photophobia in an Immunocompromised Patient.
Topics: Antiviral Agents; Choroid Diseases; Cidofovir; Cyclopentolate; Cytomegalovirus Retinitis; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunocompromised Host; Middle Aged; Mydriatics; Photophobia; Prednisolone; Renal Insufficiency, Chronic; Uveitis; Withholding Treatment | 2018 |